Acupuncture for Anxiety in Parkinson's Disease

Xiamen University30 enrolled

Overview

This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safely and effectively manage anxiety in Parkinson's Disease. Eligible subjects will receive either real or sham acupuncture THREE times weekly for a total of SIX weeks.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Parkinson Disease Anxiety

Interventions

Acupuncture to treat anxiety in Parkinson diseaseOTHER

Subjects will be randomized in a 1:1 ratio to receive sham acupuncture.

Eligibility

Sex: ALLMin age: 40 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with Parkinson's Disease by authorized Neurologist. * Patients 40-75 years of age * Patients who have significant anxiety symptom * Patients must be on a stable medication regimen for the treatment of PD Exclusion Criteria: * Patients who have had previous acupuncture within the past SIX months * Patients with dementia, depression, or sleep disorder * Patients who are currently taking medications known to affect anxiety

Outcomes

Primary Outcomes

Change in the Hamilton Anxiety Scale (HAM-A) between the treatment group.

The primary outcome measure will be the change between the baseline visit and the SIX-week time point in the Hamilton Anxiety Scale (HAM-A) between the treatment group. Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity, and 25-30 moderate to severe.

Time frame: SIX weeks

Change in the Generalized Anxiety Disorder 7-Item (GAD-7) scale between the treatment group.

The primary outcome measure will be the change between the baseline visit and the SIX-week time point in the Generalized Anxiety Disorder 7-Item (GAD-7) scale between the treatment group. Each item is scored on a scale of 0 (not at all) to 3 (Nearly Every Day), with a total score range of 0-56, where \<4 indicates Minimal Anxiety, 5-9 Mild Anxiety, 10-14 Moderate Anxiety, and 15-21 Severe Anxiety.

Time frame: SIX Weeks

Secondary Outcomes

Change in the Unified Parkinson's Disease Rating Scale between the treatment group.

A comprehensive assessment of both motor and non-motor symptoms associated with Parkinson's. The Unified Parkinson's Disease Rating Scale is made up of 42 items. These items are divided into six sections which are separately "evaluation of mentation, behavior, and mood", "self-evaluation of the activities of daily life", "clinician-scored monitored motor evaluation", "complications of therapy", "Hoehn and Yahr staging of severity of Parkinson's disease" and "Schwab and England ADL scale". The evaluation score for the first item to the 39th item is 0 to 4 points. The evaluation score for the 40th to the 42th item is 0 to 1 points. The higher score means the worse condition. This scores indicate severe symptoms.

Time frame: THREE months

Central Contacts

Yun Jin Kim, Ph.D

CONTACT

603-87055098 neurokim@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.